Expired Study
This study is not currently recruiting Study Participants on ClinicalConnection.com. If you would like to find active studies please search for clinical trials.

Fort Worth, Texas


Purpose:

The purpose of this study is to evaluate the safety and efficacy of BETOPTIC S and Timolol Gel-forming solution in pediatric patients. Patients will dose with study drug at 8 am and 8 pm daily for twelve weeks. Patients will have vision tested, slit lamp exam, blood pressure and pulse checks at each visit. Patients will have a dilated fundus exam and corneal measurements taken at first and last visit.


Criteria:

INCLUSION: - Children 5 years old and younger - require treatment for glaucoma or ocular hypertension - whose vision is 20/80 or better - have a cup-to-disc ratio of 0.8 or less EXCLUSION: - do not have abnormal fixation - IOP greater than 36 mm Hg - significant retinal disease - penetrating keratoplasty - severe ocular pathology - optic atrophy - eye surgery in the past 30 days - cardiovascular abnormalities - hypersensitivity to beta blockers


NCT ID:

NCT00061542


Primary Contact:

N/A


Backup Contact:

N/A


Location Contact:

Fort Worth, Texas
United States



There is no listed contact information for this specific location.

Site Status: N/A


Data Source: ClinicalTrials.gov

Date Processed: March 16, 2018

Modifications to this listing: Only selected fields are shown, please use the link below to view all information about this clinical trial.


Click to view Full Listing

This study is not currently recruiting Study Participants on ClinicalConnection.com. The form below is not enabled.